Effect of Time-of-Day (ToD) for Immunochemotherapy on PFS in NSCLC

Clinical trial NCT05549037 · COMPLETED

Trial details

NCT number: NCT05549037
Sponsor: Hunan Province Tumor Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2022-09-23
Primary completion: 2024-12-02
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.